Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-909-9 | CAS number: 597-82-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
GPMT (guinea pig, male): negative (test material with low purity)
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 92/69/EWG, B.6 (Guinea Pig maximization test (GPMT))
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Valid in vivo data from a guinea pig study is available.
- Species:
- guinea pig
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: D. Hall, Newchurch, Staffordshire, England.
- Age at study initiation: Approximately four to five weeks of age.
- Weight at study initiation: 292 to 339 g.
- Housing: in groups of five in suspended metal cages with wire mesh floors
- Diet: ad libitum (A vitamin C enriched guinea-pig diet FD2; hay was given weekly) diet was not analysed for nutrients, possible contaminants or microorganisms.
- Water: ad libitum (analysed weekly for contamination).
- Acclimation period: For five days prior to allocation to the main study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.
- Humidity (%): 30 - 70.
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
An additional six animals, from the same supplier, were used for the preliminary investigations. - Route:
- intradermal and epicutaneous
- Vehicle:
- coconut oil
- Concentration / amount:
- 1 % v/v in Alembicol D (A product of coconut oil, supplied by Alembic Products, Saltney, Chester, England).
- Route:
- epicutaneous, occlusive
- Vehicle:
- coconut oil
- Concentration / amount:
- 100 %
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- coconut oil
- Concentration / amount:
- 100 % and 50 % v/v in Alembicol D.
- No. of animals per dose:
- Number of animals in test group: 10
Number of animals in negative control group: 5 - Details on study design:
- RANGE FINDING TESTS:
Animals for these investigations were pre-treated with an intradermal injection of Freund's complete adjuvant, 50:50 with water for irrigation (Ph. Eur), approximately two weeks prior to the start of the preliminary investigations.
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal Injection
- Site/Area: Back (scapular region)/2 x 4 cm
- No. of injections/animal: 6 injections in pairs each.
- Test substance group (cranial; 2 injections side by side): Freund's complete adjuvant (FCA) blended (1:1, v/v) with water (Ph.Eur.).
- Test substance group (middle; 2 injections side by side): The test article (1%) in vehicle.
- Test substance group (caudal; 2 injections side by side): 50% Freund's complete adjuvant blended (1:1, v/v) with water + 1 % test article in vehicle.
- Control group (cranial; 2 injections side by side): Freund's complete adjuvant (FCA) blended (1:1, v/v) with water (Ph.Eur.).
- Control group (middle; 2 injections side by side): Vehicle.
- Control group (caudal; 2 injections side by side): 50% Freund's complete adjuvant blended (1:1, v/v) with water + vehicle
- Volume per injection: 0.1 ml
- Evaluation (hr after injection): from 24 hour till day 7
- Exposure period: Single exposure
Epicutaneous induction exposure
- Time schedule: 7 days after intradermal injection
- Site: same as intradermal injections (site was pretreated 24 hours before with 0.5 ml per site of 10% w/w sodium lauryl sulphate in petrolatum)
- Frequency of applications: Once.
- Area of application: 2 x 4 cm (on Whatman No. 3)
- Concentrations: undiluted test article (test group) and water (control group)
- Volume applied: 0.4ml/animal
- Type of coverage: occlusive (impemeable plastic adhesive tape (50 ram width "Blenderm") + adhesive bandage (50 mm width "Elastoplast")
- Duration: 48 hours
- Evaluation (hr after challenge): directly after removal of patch
B. CHALLENGE EXPOSURE (all animals)
- Frequency of exposure: once
- Time schedule: 2 weeks after termination of induction exposures
- Site: left flank
- Area of application: 2 x 2 cm (Whatman No. 3 paper)
- Concentrations: undiluted (anterior flank) and 50% (v/v) in vehicle
- Volume applied: 0.2 ml/animal
- Type of coverage: occlusive (impemeable plastic adhesive tape (50 ram width "Blenderm") + adhesive bandage (50 mm width "Elastoplast")
- Duration: 24 hours
- Evaluation (hr after challenge): 24 and 48 hours after termination of exposure
SCORING SYSTEM: OECD Draize system
Erythema and eschar formation:
No erythema 0
Slight erythema 1
Well-defined erythema 2
Moderate erythema 3
Severe erythema (beet redness) to slight eschar formation (injuries in depth) 4
Oedema formation:
No oedema 0
Slight oedema 1
Well-defined (edges of area well defined by definite raising) 2
Moderate oedema (raised approximately 1 millimetre) 3
Severe oedema (raised more than 1 millimetre and extending beyond the area of exposure) 4
OTHER
All animals were observed daily for signs of ill health or toxicity. The body weight of each guinea-pig on the main study was recorded on Day 1 (day of intradermal injections) and on the last day observations were made of dermal responses to the challenge applications. - Positive control substance(s):
- yes
- Remarks:
- The sensitivity of the guinea-pig strain used is checked periodically at HRC with hexyl cinnamic aldehyde, a known sensitiser
- Positive control results:
- See Table 1 for summary of positive control data
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Refer to Table 2
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Refer to Table 2
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Refer to Table 2
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Refer to Table 2
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Refer to Table 2
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Refer to Table 2
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Refer to Table 2
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Refer to Table 2
- Interpretation of results:
- GHS criteria not met
Reference
Table 1. Summary of positive control data using hexyl cinnamic aldehyde
M&K R&D No. |
Number of animals |
Dates of study |
Dates of receipt of HCA |
Dose levels % (aqueous dilutions) |
Results |
||||||
Induction |
Challenge |
||||||||||
Test |
Control |
Start |
Finish |
Intradermal |
Topical |
Positive |
Inconclusive |
Negative |
|||
1 |
10 |
5 |
08.12.92 |
09.01.93 |
29.10.92 |
10 |
As Supplied |
As supplied and 50 |
10/10 |
0/10 |
0/10 |
IE |
10 |
10 |
20.07.93 |
16.08.93 |
11.06.93 |
10 |
As Supplied |
As supplied and 50 |
9/10 |
0/10 |
1/10 |
2A |
10 |
10 |
15.03.94 |
11.04.94 |
11.06.93 |
10 |
As Supplied |
As supplied and 50 |
10/10 |
0/10 |
0/10 |
2D |
10 |
10 |
06.09.94 |
01.10.94 |
12.08.94 |
10 |
As Supplied |
As supplied and 50 |
9/10 |
0/10 |
1/10 |
2G* |
10 |
10 |
28.09.94 |
23.10.94 |
12.08.94 |
10 |
As Supplied |
As supplied and 50 |
10/10 |
0/10 |
0/10 |
2H |
10 |
10 |
05.10.94 |
30.10.94 |
12.08.94 |
10 |
As Supplied |
As supplied and 50 |
10/10 |
0/10 |
0/10 |
3A |
10 |
10 |
24.01.95 |
18.02.95 |
24.10.94 |
10 |
As Supplied |
As supplied and 50 |
8/10 |
1/10 |
1/10 |
Animals supplied by D. Hall Newchurch.
* Animals supplied by Interfauna (UK) Ltd.
Hexyl cinnamic aldehyde obtained from Aldrich Chemicals Co.
Table 2. Dermal reactions observed after each induction
Site |
Intradermal injection |
Topical application |
||
Test animals |
Control animals |
Test animals |
Control animals |
|
1 |
Necrosis |
Necrosis |
Slight erythema |
Slight erythema |
2 |
Slight irritation |
Slight irritation |
||
3 |
Necrosis |
Necrosis |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a dermal sensitisation study performed according to the EU Method B.6 (Skin Sensitisation) 92/69/EWG, 4-5 weeks old guinea pigs were used to test for contact sensitization of the test article (with low purity). The control group consisted of 5 animals and the test group was composed of 10 animals. Intradermal inductions were performed with 1% of the test article in Alembicol D mixed with Freund's complete adjuvant (FCA). 7 days later, topical inductions were carried out under occlusive conditions for 48 hours with the undiluted test article. Following a 2 week treatment free interval, challenge exposures were performed epicutaneously (occlusive, 24 hours) with the undiluted test article in Alembicol D. Evaluation of the skin reactions was performed 24 and 48 hours after challenge exposures. No animal showed a positive reaction in the treatment as well as the control group. Assays with the positive control substance (hexyl cinnamic aldehyde (CAS No. 101-86-0)) performed regularly in the same laboratory caused the expected reaction (1995).
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for the purpose of classification under Regulation 1272/2008. Based on the criteria laid down in Regulation (EC) No. 1272/2008, classification as a skin sensitizer is not warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.